Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: sense who wrote (177287)	8/26/2021 5:06:26 PM
From: TobagoJack	Respond to of 217739

<<Fixed it?>> Yes. Thank you. On another front, which might fix things, is that if I understand the Israeli strategy correctly, they are trying to out run the virus by chasing the elusive 80% vaccination, with jab after jab even as earlier jabs did not work or became no-longer-working due to the 6-8 months plateauing of alleged effectiveness. Interesting strategy. The phrase ‘chasing tail’ come to mind. Perhaps an easier approach would be for all to take a 30-days homecation, and reboot. stuff.co.nz Covid-19: Don't be fooled, Israel was vulnerable to Delta, says data modeller Oded Balilty/AP An ultra-Orthodox Jewish man rests after receiving his second dose of the Pfizer Covid-19 vaccine at a centre set up at a synagogue in Bnei Brak, Israel, in March, 2021. Most of Israel's population is vaccinated, but it still can't fight off a wave of Delta infections. Rachel Thomas asked Covid-19 modeller Rodney Jones what that means for New Zealand, where vaccination remains our biggest weapon. If ever there were a reason to go gangbusters on vaccinations, Israel is it, according to a leading Covid-19 modeller. Israel’s vaccine journey has outpaced the world’s. Half its citizens had received at least one Covid-19 vaccine by February this year and a country that was seeing 10,000 Covid-19 cases a day in January rocketed towards elimination. “In May, it looked like Israel was going to get to zero,” according to Rodney Jones, an economist and data expert from Wigram Capital Advisors. His modelling – showing New Zealand was on the same devastating path as Italy in March last year – was central to the Government’s decision to plunge the country into level 4 lockdown. “Early June [they] were down to like five cases per day. But our models kind of got stuck in the five to 20s,” he said. READ MORE: * The virus has evolved. Our response should as well * Covid-19 vaccines: US to offer adults booster shots, despite WHO guidance on benefits * Covid-19: Nearly 2 million doses of Pfizer vaccine given “It looked like this amazing success story, but if you look at their vaccination levels, they got stuck... So the story of Israel is getting stuck then being hit by Delta, which tells us that 60 per cent [vaccination rate] is not going to do it.” Supplied/Stuff Economist Rodney Jones, principal at Wigram Capital Advisers, said New Zealand will need the highest possible rates of vaccination if it wants to ward off future Delta outbreaks. Jones was referring the number of Israelis who had received two doses – which came up quickly but hit a plateau at 59 per cent. Even today, it remains there. Health boards in New Zealand set their own target for vaccinations and measure success as movement towards that target. But there’s only one number that counts when tracking our progress, Jones said: “Of the team of 5 million – how many are vaccinated?” Based on his firm’s modelling, at the current pace of vaccination, 75 per cent of New Zealanders will have had their first dose by November. “The challenge for us now is – does our current strategy work with Delta? Clearly the key metric is percent of vaccinated. And the UK with 73 per cent is not there yet,” he said. Asked if the government’s 80 per cent coverage target was therefore enough, Jones said: “There is no golden number, you just can never stop.” “And then you do booster shots”. Part of Israel's approach backfired as the vaccines were too close together, Jones said. This meant the effectiveness of the vaccine wore off quicker. Oded Balilty/AP An ultra-Orthodox Jewish man receives his second dose of the Pfizer-BioNTech COVID-19 vaccine at a coronavirus vaccination center set up at a synagogue in Bnei Brak, Israel, Sunday, March. 7, 2021. Stretching this out to six weeks – as New Zealand has – should increase the antibody response, public health expert Dr Michael Baker has said. Third doses of the Pfizer vaccine are now being given to Israelis who had their second dose at least five months earlier. Data from Israel’s health ministry has shown the booster shot has significantly improved protection from infection and serious illness among people aged 60 and over, compared with people who have had just two doses. “Our job right now is to get it back to zero and that’s going to be messy and difficult because the commentary I see right now is still under-estimating Delta,” Jones said. Aside from the greater transmissibility, Jones believes the grace period when dealing with Delta is about four days – the time it takes for the onset of symptoms in a newly infected person. The original strain had a grace period of about seven days, he said. “You just completely blow up with Delta if you have got an unvaccinated population. So this [outbreak] is a consequence of being too slow on the vaccine and not buying up aggressively at the start of the year, and there’s actually not a lot of excuse for that,” he said. “We have to put ourselves first, and we didn't.” Jones said case numbers so far this week support a level 4 lockdown in Auckland for at least another fortnight. Amir Levy/Getty Images A Palestinian man who works in Israel receives the first dose of a Moderna Covid-19 vaccine in March at a checkpoint between the West bank and Israel. More than two months after starting a Covid-19 vaccination campaign for its own citizens, Israel began administering the Moderna vaccine to Palestinian labourers from the West Bank who enter Israel for work. Sent from my iPad